The mechanism centers on several overlapping actions: Angiogenesis activation: BPC-157 upregulates VEGF (vascular endothelial growth factor), promoting the formation of new blood vessels that supply oxygen and nutrients to damaged tissue
This mechanism is the focus of most current research interest, particularly in studies on stubborn visceral fat and metabolic regulation
PRP delivers a more concentrated local stimulus and has stronger human clinical data
A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al